Clinical Trial Update: Selinexor in Combination With MTX+Ritu to Treat R/R CNSL [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial (NCT05698147) is evaluating selinexor in combination with methotrexate and rituximab for relapsed/refractory central nervous system l…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Central Nervous System Lymphoma

Drugs mentioned

• METHOTREXATE (METHOTREXATE)
• Rituximab (rituximab)
• Selinexor (selinexor)

Snippet

Sponsor: Tong Chen, MD | Conditions: Central Nervous System Lymphoma | Phase 1, Phase 2 | Status: RECRUITING